Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Teva Launches First Generic Zoloft

This article was originally published in The Pink Sheet Daily

Executive Summary

Pfizer counters with “authorized” generic through its Greenstone division.

You may also be interested in...



Generic Drug Sales Grew 22 Percent In 2006 Driven By Unbranded Zocor, Plavix

Sales of Teva's simvastatin were $911 million, and sales of Apotex's clopidogrel were $902 million, according to IMS Health data.

Generic Drug Sales Grew 22 Percent In 2006 Driven By Unbranded Zocor, Plavix

Sales of Teva's simvastatin were $911 million, and sales of Apotex's clopidogrel were $902 million, according to IMS Health data.

Teva Employs Brand-Like Patent Litigation To Retain Generic Zoloft Exclusivity

Firm claims in multiple lawsuits that other generic manufacturers are violating patents related to the manufacturing process for sertraline.

Related Content

Topics

UsernamePublicRestriction

Register

PS064668

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel